The investigators hope to get preliminary results for the breast cancer patients who are
given different neoadjuvant chemothetapy regimens. The patients are randomized two
chemotherapy regimens. One is anthracyclines plus taxanes for 6-8 cycles,the other is
anthracyclines plus taxanes for 3-4 cycles ,then switch tovinorelbine plus cisplatinum for
3-4 cycles.
Observational
Observational Model: Cohort, Time Perspective: Prospective
pathological complete response rate
one year
No
Zefei Jiang, MD
Principal Investigator
Hospital Affiliated Military Medical Science
China: Food and Drug Administration
307BCNeo-01
NCT01732939
May 2012
May 2014
Name | Location |
---|